Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of anti-EGFR-targeting monoclonal antibody-induced hypomagnesemia.

× No keyword cloud information.

16 in total

Review 1. Hypomagnesaemia and targeted anti-epidermal growth factor receptor (EGFR) agents.

Authors: Andreia Costa; Sabine Tejpar; Hans Prenen; Eric Van Cutsem
Journal: Target Oncol Date: 2011-11-24 Impact factor: 4.493

Review 2. Renal Toxicities of Targeted Therapies.

Authors: Anum Abbas; Mohsin M Mirza; Apar Kishor Ganti; Ketki Tendulkar
Journal: Target Oncol Date: 2015-12 Impact factor: 4.493

3. Epidermal growth factor receptor inhibitor-induced hypomagnesemia: a survey of practice patterns among Canadian gastrointestinal medical oncologists.

Authors: T Thangarasa; J Gotfrit; R A Goodwin; P A Tang; M Clemons; A Imbulgoda; M M Vickers
Journal: Curr Oncol Date: 2019-04-01 Impact factor: 3.677

Review 4. Panitumumab in the management of patients with KRAS wild-type metastatic colorectal cancer.

Authors: Christopher M Hocking; Timothy J Price
Journal: Therap Adv Gastroenterol Date: 2014-01 Impact factor: 4.409

5. Electrolyte and protein imbalance following anti-EGFR therapy in cancer patients: A comparative study.

Authors: Pius Maliakal; Andrea Ledford
Journal: Exp Ther Med Date: 2010-03-01 Impact factor: 2.447

Review 6. Renal effects of targeted anticancer therapies.

Authors: Camillo Porta; Laura Cosmai; Maurizio Gallieni; Paolo Pedrazzoli; Fabio Malberti
Journal: Nat Rev Nephrol Date: 2015-03-03 Impact factor: 28.314

Review 7. The role of targeted therapy in the treatment of advanced colorectal cancer.

Authors: Marwan Fakih
Journal: Curr Treat Options Oncol Date: 2009-02-24

8. Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.

Authors: M Fakih; M Vincent
Journal: Curr Oncol Date: 2010-07 Impact factor: 3.677

Review 9. Renal toxicity of anticancer agents targeting HER2 and EGFR.

Authors: Laura Cosmai; Maurizio Gallieni; Camillo Porta
Journal: J Nephrol Date: 2015-09-04 Impact factor: 3.902

Review 10. Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer.

Authors: Cathy Eng
Journal: Nat Rev Clin Oncol Date: 2009-04 Impact factor: 66.675